ADVERTISEMENT
ADVERTISEMENT
A 3D rendering of an antibody drug conjugate with attached cytotoxic payloads.
Supporting Antibody-Drug Conjugate Development
Industry expertise helps scientists navigate and streamline antibody-drug conjugate research and development.
Supporting Antibody-Drug Conjugate Development
Supporting Antibody-Drug Conjugate Development

Industry expertise helps scientists navigate and streamline antibody-drug conjugate research and development.

Industry expertise helps scientists navigate and streamline antibody-drug conjugate research and development.

cytotoxic t cell

A microRNA Family Drives the T Cell Response in Cancer
Niki Spahich, PhD | Nov 11, 2023 | 4 min read
When their in vitro and in vivo results conflicted, researchers took a deep dive into microRNAs’ influence on T cell memory formation.
Sartorius
Understanding the Blood Cancer Genomic Landscape 
The Scientist | Dec 13, 2022 | 1 min read
Information about the genomic and immunological characteristics of blood cancers is helping scientists discover and develop new immunotherapies.
COVID-19, SARS-CoV-2, coronavirus, pandemic, vaccine, vaccine trials, combination, mix and match, immunity, antibodies, T cells, Pfizer, Moderna, AstraZeneca, clinical trials
COVID-19 Vaccine Combos Aim to Boost Immunity
Asher Jones | Mar 9, 2021 | 6 min read
Mix-and-match shots could simplify vaccine rollout and stimulate more-robust immune responses. Ongoing clinical trials will soon give answers.
deep-sea anglerfish Melanocetus johnsonii mating parasitic male immunology adaptive immune system cytotoxic t cell antibody
For Mates to Fuse Bodies, Some Anglerfish Have Lost Immune Genes
Katarina Zimmer | Jul 30, 2020 | 6 min read
In most vertebrates, the absence of adaptive immunity would be catastrophic, but in some deep-sea angler fish species, it enables their “wild” and “wacky” mating habits.
ADVERTISEMENT